Advertisement

Topics

Key Indian Panel Go-Ahead For Novartis’ Kisqali

17:00 EDT 22 Jun 2017 | SCRIP

Just months after the US FDA cleared Kisqali, Novartis appears on course to bring the breast cancer therapy to India...

      

Related Stories

 

Original Article: Key Indian Panel Go-Ahead For Novartis’ Kisqali

NEXT ARTICLE

More From BioPortfolio on "Key Indian Panel Go-Ahead For Novartis’ Kisqali"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...